For comments, suggestions
Created with Raphaël 2.1.0 11.08.2017 Filing date 06.12.2018 Validation fee payment 31.07.2019 (A1) Patent application published 01.02.2021 AGEPI application filing date 31.05.2021 (T2) Translation of the validated European patent 05.05.2025 11.08.2025 Valid until 12.08.2026 Renewal fee to be paid until 11.08.2037 Patent will expire on

Patent in force


(210)Number of the EPO application18210763
(220)Filing date of the EPO application2017.08.11
(80)EPO patent specification publication (B)EPB nr. 52/2020, 2020.12.23
(110)EPO patent number3482754
(11)Number of the documentMD 3482754 T2
(21)Number of the applicatione 2019 0593
(71)Name(s) of applicant(s), code of the countryINTRABIO LTD, GB, GB;
(72)Name(s) of inventor(s), code of the countrySTRUPP Michael, DE;
(73)Name(s) of owner(s), code of the countryINTRABIO LTD, GB;
(54)Title of the inventionPharmaceutical compositions and uses directed to lysosomal storage disorders
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/13 (2006.01.01); A61P 25/00 (2006.01.01)
(19)CountryGB
(41)Date of publication of the application2019.07.31
(49)Date of publication of the translation of the validated European patent specification2021.05.31
(30)Priority201613828, 2016.08.11, GB; 201702552, 2017.02.16, GB; 201705762, 2017.04.10, GB; 201706854, 2017.04.28, GB
(74)Patent attorney(Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova
Up
/Inventions/details/3482754